FN1 and Alzheimer disease: AD-relevant biological pathways enriched in MCI included complement system, the coagulation cascade, lipid metabolism, and metal and vitamin D and E transport. Significant downregulation of potential markers fibronectin and C1 inhibitor was seen in the MCI cohorts.